Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA topoisomerase type I (single strand cut, ATP-independent) activity	TOP1MT TOP3B TOP1	2.45e-06	4	171	3	GO:0003917
GeneOntologyMolecularFunction	supercoiled DNA binding	HMGB1 HMGB2 TOP1	1.21e-05	6	171	3	GO:0097100
GeneOntologyMolecularFunction	four-way junction DNA binding	HMGB1 HMGB2 HMGB3 MECP2	1.82e-05	19	171	4	GO:0000400
GeneOntologyMolecularFunction	DNA binding, bending	HMGB1 HMGB2 HMGB3 TOP1	2.26e-05	20	171	4	GO:0008301
GeneOntologyMolecularFunction	DNA topoisomerase activity	TOP1MT TOP3B TOP1	3.35e-05	8	171	3	GO:0003916
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	7.29e-05	2	171	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	7.29e-05	2	171	2	GO:0044017
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	2.18e-04	3	171	2	GO:0043993
GeneOntologyMolecularFunction	RAGE receptor binding	HMGB1 HMGB2 S100A8	2.60e-04	15	171	3	GO:0050786
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	CREBBP MCM3AP EP300	2.60e-04	15	171	3	GO:0010484
GeneOntologyMolecularFunction	DNA secondary structure binding	HMGB1 HMGB2 HMGB3 MECP2	4.11e-04	41	171	4	GO:0000217
GeneOntologyMolecularFunction	N-acetyltransferase activity	NAT8L NAA15 CREBBP MCM3AP EP300	5.54e-04	78	171	5	GO:0008080
GeneOntologyBiologicalProcess	DNA topological change	HMGB1 HMGB2 TOP1MT TOP3B TOP1	8.48e-09	10	169	5	GO:0006265
GeneOntologyBiologicalProcess	DNA conformation change	MCM8 HMGB1 HMGB2 HMGB3 RAD54B TOP1MT DNA2 TOP3B TOP1	7.88e-08	94	169	9	GO:0071103
GeneOntologyBiologicalProcess	DNA damage response	CUL4A CIDEB SMG1 VPS72 FLYWCH1 MCM8 UACA SGK1 RRM2B HMGB1 HMGB2 SSRP1 CREBBP RINT1 YEATS4 PSME4 SMC3 RAD54B PRKDC DNA2 MNDA TOP3B EP300	3.76e-06	959	169	23	GO:0006974
GeneOntologyBiologicalProcess	N-terminal protein amino acid acetylation	NAA15 CREBBP NAA25 EP300	7.33e-06	16	169	4	GO:0006474
GeneOntologyBiologicalProcess	DNA metabolic process	CUL4A SMG1 VPS72 MCM8 RRM2B HMGB1 HMGB2 HMGB3 SSRP1 CREBBP YEATS4 PSME4 SMC3 PRIM1 RAD54B XRN1 PRKDC TOP1MT DNA2 TOP3B TOP1 PGBD5 AURKB	2.59e-05	1081	169	23	GO:0006259
GeneOntologyBiologicalProcess	DNA geometric change	MCM8 HMGB1 HMGB2 HMGB3 RAD54B DNA2	7.57e-05	86	169	6	GO:0032392
GeneOntologyBiologicalProcess	N-terminal protein amino acid modification	NAA15 CREBBP NAA25 EP300	8.80e-05	29	169	4	GO:0031365
GeneOntologyBiologicalProcess	DNA repair	CUL4A SMG1 VPS72 MCM8 RRM2B HMGB1 HMGB2 SSRP1 CREBBP YEATS4 PSME4 SMC3 RAD54B PRKDC DNA2 TOP3B	8.89e-05	648	169	16	GO:0006281
Domain	HMG_boxA_CS	HMGB1 HMGB2 HMGB3	7.15e-07	3	168	3	IPR017967
Domain	HMG_box_2	HMGB1 HMGB2 HMGB3	5.77e-05	9	168	3	PF09011
Domain	TPR-contain_dom	NAA15 TMTC2 NAA25 VPS13A PDCD11 TTC13 PRKDC LONRF2	6.46e-05	150	168	8	IPR013026
Domain	DNA_brk_join_enz	TOP1MT TOP1	8.04e-05	2	168	2	IPR011010
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	8.04e-05	2	168	2	IPR014744
Domain	TopoI_cat_a/b-sub_euk	TOP1MT TOP1	8.04e-05	2	168	2	IPR014727
Domain	ZnF_TAZ	CREBBP EP300	8.04e-05	2	168	2	SM00551
Domain	TopoI	TOP1MT TOP1	8.04e-05	2	168	2	IPR001631
Domain	TopoI_cat_a-hlx-sub_euk	TOP1MT TOP1	8.04e-05	2	168	2	IPR014711
Domain	TopoI_C_dom	TOP1MT TOP1	8.04e-05	2	168	2	IPR025834
Domain	-	TOP1MT TOP1	8.04e-05	2	168	2	1.10.132.10
Domain	-	CREBBP EP300	8.04e-05	2	168	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	8.04e-05	2	168	2	IPR010303
Domain	-	CREBBP EP300	8.04e-05	2	168	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	8.04e-05	2	168	2	PF09030
Domain	zf-TAZ	CREBBP EP300	8.04e-05	2	168	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	8.04e-05	2	168	2	PS50134
Domain	Topoisom_I	TOP1MT TOP1	8.04e-05	2	168	2	PF01028
Domain	TopoI_AS	TOP1MT TOP1	8.04e-05	2	168	2	IPR018521
Domain	DNA_topo_domain1	TOP1MT TOP1	8.04e-05	2	168	2	IPR013034
Domain	TopoI_DNA-bd_mixed-a/b_euk	TOP1MT TOP1	8.04e-05	2	168	2	IPR013030
Domain	KAT11	CREBBP EP300	8.04e-05	2	168	2	SM01250
Domain	-	TOP1MT TOP1	8.04e-05	2	168	2	1.10.10.41
Domain	TopoI_euk	TOP1MT TOP1	8.04e-05	2	168	2	IPR013499
Domain	Znf_TAZ	CREBBP EP300	8.04e-05	2	168	2	IPR000197
Domain	-	TOP1MT TOP1	8.04e-05	2	168	2	2.170.11.10
Domain	KIX	CREBBP EP300	8.04e-05	2	168	2	PF02172
Domain	Topo_C_assoc	TOP1MT TOP1	8.04e-05	2	168	2	PF14370
Domain	HAT_KAT11	CREBBP EP300	8.04e-05	2	168	2	PF08214
Domain	KIX	CREBBP EP300	8.04e-05	2	168	2	PS50952
Domain	Topoisom_I_N	TOP1MT TOP1	8.04e-05	2	168	2	PF02919
Domain	TOPEUc	TOP1MT TOP1	8.04e-05	2	168	2	SM00435
Domain	CBP_P300_HAT	CREBBP EP300	8.04e-05	2	168	2	IPR031162
Domain	DUF902	CREBBP EP300	8.04e-05	2	168	2	PF06001
Domain	TopoI_cat_euk	TOP1MT TOP1	8.04e-05	2	168	2	IPR013500
Domain	TopoI_DNA-bd_euk	TOP1MT TOP1	8.04e-05	2	168	2	IPR008336
Domain	-	TOP1MT TOP1	8.04e-05	2	168	2	3.90.15.10
Domain	-	CREBBP EP300	8.04e-05	2	168	2	1.10.246.20
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	8.04e-05	2	168	2	IPR013178
Domain	KIX_dom	CREBBP EP300	8.04e-05	2	168	2	IPR003101
Domain	CBP_P300_HAT	CREBBP EP300	8.04e-05	2	168	2	PS51727
Domain	TOPOISOMERASE_I_EUK	TOP1MT TOP1	8.04e-05	2	168	2	PS00176
Domain	HMG_BOX_1	HMGB1 HMGB2 HMGB3	8.19e-05	10	168	3	PS00353
Domain	ARM-type_fold	SMG1 DOCK9 APOB HEATR1 ODAD2 PSME4 RNPEP CEBPZ PRKDC WDFY3 ARMH3	2.57e-04	339	168	11	IPR016024
Domain	HEAT_REPEAT	SMG1 HEATR1 ODAD2 PSME4 PRKDC	4.19e-04	70	168	5	PS50077
Domain	Nebulin	NRAP NEB	4.77e-04	4	168	2	PF00880
Domain	NEBULIN	NRAP NEB	4.77e-04	4	168	2	PS51216
Domain	NEBU	NRAP NEB	4.77e-04	4	168	2	SM00227
Domain	Nebulin	NRAP NEB	4.77e-04	4	168	2	IPR013998
Domain	DUF3338	FRMD4B FRMD4A	4.77e-04	4	168	2	PF11819
Domain	DUF3338	FRMD4B FRMD4A	4.77e-04	4	168	2	IPR021774
Domain	Nebulin_repeat	NRAP NEB	4.77e-04	4	168	2	IPR000900
Domain	TPR_REGION	NAA15 TMTC2 NAA25 VPS13A TTC13 PRKDC LONRF2	7.43e-04	165	168	7	PS50293
Domain	TPR	NAA15 TMTC2 NAA25 VPS13A TTC13 PRKDC LONRF2	7.43e-04	165	168	7	PS50005
Domain	HnRNP_R/Q_splicing_fac	RBM47 SYNCRIP	7.90e-04	5	168	2	IPR006535
Domain	FATC	SMG1 PRKDC	7.90e-04	5	168	2	PF02260
Domain	Nuc_rcpt_coact	CREBBP EP300	1.18e-03	6	168	2	IPR009110
Domain	FAT	SMG1 PRKDC	1.18e-03	6	168	2	PS51189
Domain	FATC	SMG1 PRKDC	1.18e-03	6	168	2	PS51190
Domain	FATC_dom	SMG1 PRKDC	1.18e-03	6	168	2	IPR003152
Domain	PIK_FAT	SMG1 PRKDC	1.18e-03	6	168	2	IPR014009
Domain	FATC	SMG1 PRKDC	1.18e-03	6	168	2	SM01343
Domain	TPR-like_helical_dom	SAMD9 NAA15 TMTC2 NAA25 PDCD11 TTC13 PRKDC LONRF2	1.25e-03	233	168	8	IPR011990
Domain	HMG_box	HMGB1 HMGB2 HMGB3 SSRP1	1.31e-03	53	168	4	PF00505
Domain	HMG_BOX_2	HMGB1 HMGB2 HMGB3 SSRP1	1.41e-03	54	168	4	PS50118
Domain	HMG	HMGB1 HMGB2 HMGB3 SSRP1	1.41e-03	54	168	4	SM00398
Domain	-	HMGB1 HMGB2 HMGB3 SSRP1	1.51e-03	55	168	4	1.10.30.10
Domain	HMG_box_dom	HMGB1 HMGB2 HMGB3 SSRP1	2.79e-03	65	168	4	IPR009071
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 PDE6A ANK2 HMGB1 HMGB2 HMGB3 SPG11 RGS11 APOB VPS36 HEATR1 SSRP1 NEB PLA2G4D MECP2 CHRNA1 RINT1 CEBPZ VPS13A XRN1 PRKDC TOP1MT TASOR MNDA TOP3B TOP1 DOP1A SYNCRIP	9.13e-10	1442	175	28	35575683
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 SLC4A7 NAA15 ANK2 UACA CYP51A1 SPG11 SEC22B HEATR1 DNAJC22 SSRP1 MRPL39 RINT1 TRMT10C CCDC88A SLC25A40 SNX6 CEBPZ MACO1 VPS13A PDCD11 TTC13 DNA2 PLOD2 TOP3B SYNCRIP	3.26e-08	1487	175	26	33957083
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	SLC4A7 NAA15 HMGB1 RNF213 SEC22B HEATR1 IDH2 SSRP1 MRPL39 RINT1 IGF2BP1 TRMT10C MIGA2 SLC25A40 SNX6 MACO1 VPS13A PDCD11 TTC13 HADH TOP3B TOP1 PGBD5 MOV10 SYNCRIP CHP1	3.67e-08	1496	175	26	32877691
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	CUL4A FLYWCH1 UACA MATN2 APOB HEATR1 SSRP1 MYO5C NEDD9 S100A8 IGF2BP1 SMC3 CEBPZ PDCD11 PRKDC TOP1MT TOP1 MOV10 SYNCRIP AURKB	7.73e-08	949	175	20	36574265
Pubmed	Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.	HMGB1 HMGB2 HMGB3	1.25e-07	3	175	3	31621076
Pubmed	High mobility group proteins 1 and 2 can function as DNA-binding regulatory components for DNA-dependent protein kinase in vitro.	HMGB1 HMGB2 PRKDC	1.25e-07	3	175	3	9722660
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	SMG1 HMGB1 HMGB2 HMGB3 HEATR1 SSRP1 IGF2BP1 TRMT10C CEBPZ XRN1 PDCD11 PRKDC RBM47 HNRNPLL TOP3B TOP1 MOV10 SYNCRIP	1.57e-07	807	175	18	22681889
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FLYWCH1 UACA RNF213 IGDCC4 OGFOD1 DNAH5 MOV10	8.36e-07	101	175	7	10997877
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	UACA RNF213 SEC22B MCM3AP CTDP1 EP300 CHP1	1.02e-06	104	175	7	31240132
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	CUL4A UACA RNF213 HEATR1 SSRP1 SNX6 CEBPZ MCM3AP XRN1 PDCD11 TASOR	1.09e-06	332	175	11	25693804
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SMG1 SAMD9 NAA15 MCM8 RINT1 CCDC88A PSME4 RAD54B PRSS21 XRN1 OGFOD1 DNA2 RBM47 TASOR IQGAP3	1.18e-06	650	175	15	38777146
Pubmed	CRL4-DCAF12 Ubiquitin Ligase Controls MOV10 RNA Helicase during Spermatogenesis and T Cell Activation.	CUL4A IL17RB MOV10	1.24e-06	5	175	3	34065512
Pubmed	Distinct embryonic expression and localization of CBP and p300 histone acetyltransferases at the mouse alphaA-crystallin locus in lens.	CREBBP CRYAA EP300	1.24e-06	5	175	3	17467007
Pubmed	HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses.	HMGB1 HMGB2 HMGB3	1.24e-06	5	175	3	19890330
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	SEC22B HEATR1 IDH2 SSRP1 IGF2BP1 SMC3 CEBPZ PDCD11 PRKDC DNAH5 HNRNPLL TOP1 IQGAP3 MOV10 AURKB	3.12e-06	704	175	15	29955894
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 CASP8AP2 SPAST FLYWCH1 HECTD4 SPG11 FRMD4B CCDC88A PSME4 PDCD11 DNA2 CRAMP1 IGSF3	3.15e-06	529	175	13	14621295
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CUL4A HTRA1 VPS72 MCM8 UACA GPT QTRT2 RNF213 SSRP1 CREBBP MECP2 YEATS4 MCM3AP XRN1 WDFY3 DNA2 TOP1 EP300 AURKB	3.95e-06	1116	175	19	31753913
Pubmed	A unique SUMO-2-interacting motif within LANA is essential for KSHV latency.	CREBBP PRKDC EP300	4.32e-06	7	175	3	24278015
Pubmed	In vitro acetylation of HMGB-1 and -2 proteins by CBP: the role of the acidic tail.	HMGB1 HMGB2 CREBBP	4.32e-06	7	175	3	15005629
Pubmed	Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.	PPP3CC SMC3 XRN1 PRKDC TOP1 MOV10	5.37e-06	87	175	6	17148452
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	SAMD9 NAA15 UACA HMGB1 HMGB2 HEATR1 SSRP1 MECP2 MRPL39 TRMT10C SMC3 CEBPZ PRIM1 PDCD11 PRKDC TOP1 IQGAP3 MOV10 SYNCRIP AURKB	5.92e-06	1257	175	20	36526897
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	HEATR1 SSRP1 IGF2BP1 SMC3 CEBPZ XRN1 PDCD11 PRKDC TASOR TOP3B TOP1 IQGAP3 MOV10 SYNCRIP AURKB	7.67e-06	759	175	15	35915203
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	HMGB2 IDH2 SSRP1 IGF2BP1 TRMT10C PRKDC TOP1 SYNCRIP AURKB CHP1	8.23e-06	334	175	10	30425250
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	NAA15 JMJD4 QTRT2 SEC22B HEATR1 MRPL39 IGF2BP1 TRMT10C SNX6 SMC3 MACO1 XRN1 TTC13 PRKDC HNRNPLL ABTB2 SYNCRIP	9.50e-06	974	175	17	28675297
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HMGB1 SEC22B APOB HEATR1 IDH2 SSRP1 S100A8 IGF2BP1 TRMT10C RNPEP SMC3 CEBPZ PRIM1 PDCD11 PRKDC DNAH5 HNRNPLL TOP1 IQGAP3 TMEM117 SYNCRIP	1.09e-05	1425	175	21	30948266
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	HMGB1 HEATR1 SSRP1 MECP2 IGF2BP1 SMC3 VPS13A PDCD11 TOP1 MOV10 SYNCRIP	1.27e-05	430	175	11	38172120
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SMG1 UACA HMGB1 QTRT2 RNF213 SEC22B HEATR1 IDH2 SSRP1 RINT1 IGF2BP1 TRMT10C CEBPZ MACO1 COMMD10 PDCD11 PRKDC PLOD2 MOV10 SYNCRIP CHP1	1.28e-05	1440	175	21	30833792
Pubmed	The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.	CUL4A CREBBP EP300	1.46e-05	10	175	3	20347598
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL4A CASP8AP2 ANXA4 HMGB1 RNF213 HMGB2 HMGB3 SSRP1 CREBBP RNPEP SMC3 PRIM1 PRKDC HNRNPLL TOP1 EP300 AURKB	1.59e-05	1014	175	17	32416067
Pubmed	Interaction proteomics of the HMGA chromatin architectural factors.	HMGB1 HMGB2 HMGB3 SYNCRIP	2.00e-05	32	175	4	18850631
Pubmed	Histone posttranslational modifications and cell fate determination: lens induction requires the lysine acetyltransferases CBP and p300.	CREBBP CRYAA EP300	2.01e-05	11	175	3	24038357
Pubmed	Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.	HEATR1 SPATA2 CREBBP SLC25A40 SP140L VPS13A PRKDC ARMH3 CRAMP1 SYNCRIP AURKB	2.23e-05	457	175	11	32968282
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	UACA DOCK9 HMGB1 HMGB2 HMGB3 SSRP1 EFHB HMGB1P1 MRPL39 S100A8 IGF2BP1 TRMT10C SMC3 PDCD11 PRKDC TOP1 MOV10 SYNCRIP	2.29e-05	1153	175	18	29845934
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	2.52e-05	2	175	2	27881875
Pubmed	Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism.	TOP1MT TOP1	2.52e-05	2	175	2	22911747
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	2.52e-05	2	175	2	34845315
Pubmed	Cloning and analysis of an HMG gene from the lamprey Lampetra fluviatilis: gene duplication in vertebrate evolution.	HMGB1 HMGB2	2.52e-05	2	175	2	9016958
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	2.52e-05	2	175	2	19729597
Pubmed	A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings.	SPAST GPT	2.52e-05	2	175	2	27260292
Pubmed	Hmg4, a new member of the Hmg1/2 gene family.	HMGB1 HMGB3	2.52e-05	2	175	2	9598312
Pubmed	CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case-control study.	CYP2C9 ABCG2	2.52e-05	2	175	2	24024895
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	2.52e-05	2	175	2	39287984
Pubmed	Evidence for a shared structural role for HMG1 and linker histones B4 and H1 in organizing chromatin.	HMGB1 HMGB2	2.52e-05	2	175	2	8599938
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	2.52e-05	2	175	2	20717166
Pubmed	DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.	PRKDC TOP1	2.52e-05	2	175	2	26578593
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	2.52e-05	2	175	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	2.52e-05	2	175	2	11559821
Pubmed	P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation.	IDH2 CREBBP	2.52e-05	2	175	2	30526058
Pubmed	The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.	HMGB1 HMGB2	2.52e-05	2	175	2	25060178
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	2.52e-05	2	175	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	2.52e-05	2	175	2	19822209
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	2.52e-05	2	175	2	24522976
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	2.52e-05	2	175	2	21847097
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	2.52e-05	2	175	2	34813504
Pubmed	Lack of mitochondrial topoisomerase I (TOP1mt) impairs liver regeneration.	TOP1MT TOP1	2.52e-05	2	175	2	26305952
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	2.52e-05	2	175	2	20301699
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	2.52e-05	2	175	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	2.52e-05	2	175	2	37816914
Pubmed	Binding of p300/CBP co-activators by polyoma large T antigen.	CREBBP EP300	2.52e-05	2	175	2	11438528
Pubmed	Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.	CREBBP EP300	2.52e-05	2	175	2	10918613
Pubmed	Mitochondrial topoisomerase I sites in the regulatory D-loop region of mitochondrial DNA.	TOP1MT TOP1	2.52e-05	2	175	2	18826252
Pubmed	Histone Acetyltransferases p300 and CBP Coordinate Distinct Chromatin Remodeling Programs in Vascular Smooth Muscle Plasticity.	CREBBP EP300	2.52e-05	2	175	2	35502657
Pubmed	p300 and cAMP response element-binding protein-binding protein in skeletal muscle homeostasis, contractile function, and survival.	CREBBP EP300	2.52e-05	2	175	2	31898871
Pubmed	Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.	CREBBP EP300	2.52e-05	2	175	2	30888860
Pubmed	cDNA sequence and structure of a trout HMG-2 gene. Evidence for a trout-specific 3'-untranslated region.	HMGB1 HMGB2	2.52e-05	2	175	2	7607539
Pubmed	Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.	CREBBP EP300	2.52e-05	2	175	2	27881443
Pubmed	Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts.	CREBBP EP300	2.52e-05	2	175	2	19272189
Pubmed	HMGB proteins and arthritis.	HMGB1 HMGB2	2.52e-05	2	175	2	28916968
Pubmed	Recent integrations of mammalian Hmg retropseudogenes.	HMGB1 HMGB2	2.52e-05	2	175	2	17406091
Pubmed	Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.	CREBBP EP300	2.52e-05	2	175	2	32690000
Pubmed	CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.	CREBBP EP300	2.52e-05	2	175	2	30953353
Pubmed	Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.	CREBBP EP300	2.52e-05	2	175	2	21803292
Pubmed	HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.	CREBBP EP300	2.52e-05	2	175	2	9811832
Pubmed	Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.	CREBBP EP300	2.52e-05	2	175	2	24089570
Pubmed	SNARE protein SEC22B regulates early embryonic development.	SEC22B COMMD10	2.52e-05	2	175	2	31391476
Pubmed	Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease.	CREBBP EP300	2.52e-05	2	175	2	15706485
Pubmed	AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.	CREBBP EP300	2.52e-05	2	175	2	39266679
Pubmed	A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.	CREBBP EP300	2.52e-05	2	175	2	22303793
Pubmed	Interactions of HMGB Proteins with the Genome and the Impact on Disease.	HMGB1 HMGB2	2.52e-05	2	175	2	34680084
Pubmed	Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.	CREBBP EP300	2.52e-05	2	175	2	34732714
Pubmed	Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.	CREBBP EP300	2.52e-05	2	175	2	34019788
Pubmed	The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.	CD80 PRKDC	2.52e-05	2	175	2	15983204
Pubmed	Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm.	ODAD2 DNAH5	2.52e-05	2	175	2	24203976
Pubmed	Endogenous CCAAT/enhancer binding protein beta and p300 are both regulated by growth hormone to mediate transcriptional activation.	CREBBP EP300	2.52e-05	2	175	2	15860545
Pubmed	Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome.	CREBBP EP300	2.52e-05	2	175	2	29460469
Pubmed	Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.	CREBBP EP300	2.52e-05	2	175	2	24551300
Pubmed	Progressive Changes in a Distributed Neural Circuit Underlie Breathing Abnormalities in Mice Lacking MeCP2.	MECP2 HOXB1	2.52e-05	2	175	2	27194336
Pubmed	Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.	ABCG2 TOP1	2.52e-05	2	175	2	26801902
Pubmed	Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response.	HMGB1 HMGB2	2.52e-05	2	175	2	24684392
Pubmed	Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.	CREBBP EP300	2.52e-05	2	175	2	33911074
Pubmed	The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.	CREBBP EP300	2.52e-05	2	175	2	9018065
Pubmed	Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure.	CREBBP EP300	2.52e-05	2	175	2	24648406
Pubmed	CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity.	CREBBP EP300	2.52e-05	2	175	2	30135524
Pubmed	DNA-dependent protein kinase interacts functionally with the RNA polymerase II complex recruited at the human immunodeficiency virus (HIV) long terminal repeat and plays an important role in HIV gene expression.	CTDP1 PRKDC	2.52e-05	2	175	2	21450944
Pubmed	Distribution of co-activators CBP and p300 during mouse oocyte and embryo development.	CREBBP EP300	2.52e-05	2	175	2	16596650
Pubmed	The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures.	HMGB1 HMGB2	2.52e-05	2	175	2	8339930
Pubmed	Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks.	HMGB1 HMGB2	2.52e-05	2	175	2	9600082
Pubmed	The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.	CREBBP EP300	2.52e-05	2	175	2	29217654
Pubmed	Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.	CREBBP EP300	2.52e-05	2	175	2	10049825
Pubmed	CBP/p300 acetyltransferase activity in hematologic malignancies.	CREBBP EP300	2.52e-05	2	175	2	27380996
Interaction	CTDP1 interactions	UACA HMGB1 RNF213 SEC22B MCM3AP CTDP1 PRKDC TOP3B EP300 AURKB CHP1	1.92e-06	207	174	11	int:CTDP1
Interaction	IWS1 interactions	HMGB1 SSRP1 MECP2 CCDC88A CTDP1 TOP1 EP300 MOV10	7.56e-06	116	174	8	int:IWS1
Interaction	HMGB3 interactions	HMGB1 HMGB2 HMGB3 SSRP1 MECP2 TOP1 MOV10	1.50e-05	92	174	7	int:HMGB3
GeneFamily	Topoisomerases	TOP1MT TOP3B TOP1	5.76e-06	6	121	3	1050
GeneFamily	Canonical high mobility group	HMGB1 HMGB2 HMGB3	4.64e-05	11	121	3	511
Coexpression	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	SLC4A7 MECP2 FBXO38 RINT1 PSME4 PGAP1 MCM3AP VPS13A HERC3 EP300 DOP1A	1.05e-07	200	174	11	M9889
Coexpression	FISCHER_DREAM_TARGETS	CASP8AP2 NAA15 MCM8 UACA CYP51A1 HMGB1 HMGB2 HMGB3 HEATR1 SSRP1 YEATS4 SLC25A40 SMC3 PRIM1 RAD54B MTBP PRKDC HADH DNA2 TOP1 IQGAP3 SYNCRIP AURKB	1.28e-07	969	174	23	M149
Coexpression	FEVR_CTNNB1_TARGETS_DN	CASP8AP2 CYP2C9 SLC4A7 NAA15 MATN2 HMGB1 HMGB2 HMGB3 SSRP1 RWDD3 SLC13A1 SMC3 PRIM1 MTBP HADH AURKB	1.00e-06	555	174	16	M2343
Coexpression	ONKEN_UVEAL_MELANOMA_UP	CASP8AP2 HTRA1 SPAST ANK2 SGK1 ANXA4 DOCK9 CYP51A1 HMGB2 IDH2 FRMD4B PSME4 PGAP1 MCM3AP RAD54B PRKDC ABTB2 SYNCRIP	5.76e-06	790	174	18	M12490
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CASP8AP2 NAA15 MATN2 RRM2B HMGB1 SPG11 RINT1 TRMT10C CCDC88A YEATS4 CSGALNACT2 SMC3 CEBPZ RAD54B TASOR SLC16A7	8.45e-06	656	174	16	M18979
Coexpression	NUYTTEN_EZH2_TARGETS_DN	SLC4A7 SPAST MCM8 RRM2B JMJD4 HMGB1 HMGB2 HMGB3 HEATR1 DNAJC22 SSRP1 SMC3 PRIM1 RAD54B MTBP TOP1MT DNA2 RBM47 IQGAP3 AURKB	1.62e-05	1023	174	20	M17122
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	RRM2B HMGB1 HMGB2 SSRP1 SMC3 RAD54B PRKDC TOP3B TOP1	2.46e-05	230	174	9	M11563
Coexpression	BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES	CIDEB CYP2C9 SLC4A7 ANXA4 APOB MEP1A ABCG2 RBM47	2.52e-05	177	174	8	M40028
Coexpression	ISHIDA_E2F_TARGETS	HMGB2 HMGB3 PRIM1 DNA2 AURKB	2.70e-05	53	174	5	M1945
Coexpression	GCNP_SHH_UP_LATE.V1_UP	CUL4A NAA15 IDH2 SERPINB9 PSME4 CD80 AURKB CHP1	2.96e-05	181	174	8	M2641
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	RNF213 NEB FRMD4B YEATS4 PRIM1 PLOD2 HNRNPLL AURKB	3.20e-05	183	174	8	M2993
Coexpression	ISHIDA_E2F_TARGETS	HMGB2 HMGB3 PRIM1 DNA2 AURKB	3.24e-05	55	174	5	MM1264
Coexpression	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	SMG1 NAT8L RRM2B DNAJC22 SSRP1 NEB PRKDC RSPH9	6.00e-05	200	174	8	M6044
Coexpression	GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	UACA RNF213 IL18R1 NRP2 HOXB1 SERPINB9 ABTB2 MCOLN3	6.00e-05	200	174	8	M6256
Coexpression	GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP	NAA15 ANXA4 FRMD4B SERPINB9 PPP3CC CD80 DNA2 CRAMP1	6.00e-05	200	174	8	M9261
Coexpression	GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP	ANXA4 HMGB3 S100A8 SERPINB9 PRIM1 DNA2 IQGAP3 AURKB	6.00e-05	200	174	8	M3041
Coexpression	BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES	CIDEB CYP2C9 SLC4A7 UACA SGK1 APOB MIGA2 ABCG2 INPP5J	6.19e-05	259	174	9	M40029
Coexpression	JOHNSTONE_PARVB_TARGETS_2_DN	DOCK9 SEC22B SLC25A40 SMC3 VPS13A XRN1 HADH SLC16A7 HNRNPLL SYNCRIP	1.07e-04	344	174	10	M2239
Coexpression	OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	VPS72 HEATR1 FRMD4A SLC13A1 OGFOD1 ZNF749 HABP2 TOP3B PGBD5 IL17RB	1.21e-04	349	174	10	M283
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	SLC4A7 TMTC2 DNAH14 RBM47 DNAH5 PLOD2 SLC16A7	1.41e-04	169	174	7	M39230
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CIDEB SMG1 SAMD9 SLC4A7 DOCK9 HECTD4 HMGB1 RNF213 SPG11 IL18R1 CREBBP MECP2 NEDD9 SERPINB9 CCDC88A PPP3CC CSGALNACT2 SMC3 XRN1 TASOR SLC16A7 HNRNPLL EP300	1.45e-04	1492	174	23	M40023
Coexpression	TIEN_INTESTINE_PROBIOTICS_6HR_DN	SPAST SGK1 DOCK9 SPATA2 YEATS4 PSME4 SNX6	1.46e-04	170	174	7	M19990
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CASP8AP2 FBLN7 MCM8 HMGB1 PRIM1 RAD54B MTBP PRKDC DNA2	7.91e-08	195	174	9	cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 HADH AURKB	9.41e-08	199	174	9	99778178e3ec121802db938db8c5475d19b43fec
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CASP8AP2 FBLN7 MCM8 RAD54B PRKDC DNA2 IQGAP3 AURKB	5.42e-07	179	174	8	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIDEB NAT8L HTRA1 APOB SLC13A1 HABP2 ABCG2 THNSL2	6.67e-07	184	174	8	3d7dd193a0826cc7a4e454a29236a16c315e5965
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SAMD9 RNF213 SERPINB9 CD80 XRN1 HNRNPLL ABTB2 MOV10	9.56e-07	193	174	8	22455801194bd8c73c5c397f5eac4f723429c383
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CASP8AP2 FBLN7 MCM8 HMGB1 PRIM1 RAD54B MTBP DNA2	1.03e-06	195	174	8	56d8734d020b3da08a5aa9e67999706a9e023a99
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CASP8AP2 FBLN7 MCM8 PRIM1 RAD54B MTBP PRKDC DNA2	1.07e-06	196	174	8	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	HMGB2 HMGB3 IDH2 SSRP1 MRPL39 RNPEP DNA2 AURKB	1.07e-06	196	174	8	36ed1918f70b6f5760bb088b15ce422998055cc7
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MCF2L2 OVCH1 FRMD4A CCDC88A ABCG2 DNA2 IQGAP3 AURKB	1.12e-06	197	174	8	d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 HMGB2 HMGB3 YEATS4 PPP3CC SMC3 HADH AURKB	1.20e-06	199	174	8	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	HMGB1 HMGB2 HMGB3 SMC3 PRIM1 PRKDC HADH AURKB	1.25e-06	200	174	8	548a0f486ab8745da107f2815914dbf873a6e3c8
ToppCell	C_02\|World / shred on cell type and cluster	CIDEB SLC4A7 SGK1 MATN2 APOB MEP1A ABCG2	3.98e-06	165	174	7	a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	HMGB3 S100A8 CCDC88A WDFY3 MNDA IQGAP3 AURKB	5.44e-06	173	174	7	783b8fa08b9d8f597f251793eae164151662f1f9
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMGB2 SMC3 PRIM1 RAD54B MTBP CRAMP1 AURKB	5.65e-06	174	174	7	c988471207ba06195bc3e41056435e8c31c20bbe
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ANK2 MCM8 HMGB3 MTBP ABCG2 IQGAP3 AURKB	5.87e-06	175	174	7	bde785ff0c854646d7ab8571359e9d69a7bf013f
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	SAMD9 SGK1 RNF213 FRMD4B PGAP1 XRN1 LONRF2	6.56e-06	178	174	7	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 RNF213 NAA25 PGAP1 XRN1 TOP1 MOV10	6.80e-06	179	174	7	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASP8AP2 HTRA1 MCM8 HMGB2 PRIM1 RAD54B IQGAP3	6.80e-06	179	174	7	9dea57494d59abd6e8abf34e31faf53462ea0fa0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HMGB1 HMGB2 HMGB3 NMU FBXL5 IQGAP3 AURKB	6.80e-06	179	174	7	6718cadcc2d3b64717ed84244ef1242d392662dc
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PDE6A S100A8 CSGALNACT2 GOLGA1 EP300	6.99e-06	68	174	5	f1cbc6d72489272c1eb6200f64b8b6444719acda
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 CCDC88A PGAP1 XRN1 MNDA RSPH9 EP300	7.58e-06	182	174	7	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 PHYHIP IDH2 KCNJ1 SLC16A7 TOP3B INPP5J	7.86e-06	183	174	7	f3728b1a51951c7349f77a3e4d2671ca3a8d2a44
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L HTRA1 APOB SLC13A1 HABP2 ABCG2 THNSL2	8.14e-06	184	174	7	c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L HTRA1 APOB SLC13A1 HABP2 ABCG2 THNSL2	8.14e-06	184	174	7	7c256bcfa07c5ff55aad0833e8712b0456b5832b
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L HTRA1 APOB SLC13A1 HABP2 ABCG2 THNSL2	8.14e-06	184	174	7	45577ff91c3b2b303acd97239dde2463ea7a429c
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 PHYHIP IDH2 KCNJ1 SLC16A7 TOP3B INPP5J	8.14e-06	184	174	7	8939b6d795992775df0ff58ed1ec9d421a00bcc4
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|bone_marrow / Manually curated celltypes from each tissue	HMGB2 HMGB3 S100A8 CCDC88A RBM47 MNDA AURKB	8.74e-06	186	174	7	e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 RNF213 NAA25 PGAP1 XRN1 TOP1 MOV10	9.37e-06	188	174	7	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RGS11 ODAD2 CFAP100 PPP1R36 DNAH5 RSPH9 RSPH10B	9.70e-06	189	174	7	b55de812043b670cbde810d7d42f45909b6d66ef
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RGS11 ODAD2 CFAP100 PPP1R36 DNAH5 RSPH9 RSPH10B	9.70e-06	189	174	7	4e83e49d1265ffe507fdb72924c77c4d1c73f0bd
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HMGB1 HMGB2 HMGB3 FBXL5 CCDC88A IQGAP3 AURKB	1.00e-05	190	174	7	cd37ccd30c27cf65eda0a9165f35b7672f5acaf6
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RRM2B FBXL5 SLC25A40 RABGEF1 HERC3 DNA2 IQGAP3	1.00e-05	190	174	7	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	CYP51A1 RNF213 HEATR1 ANKRD36C IL18R1 PRKDC DNA2	1.04e-05	191	174	7	9454f642c3621370fa23640b631301346b300950
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NAT8L SLC4A7 ANK2 IDH2 NEB KCNJ1 SLC16A7	1.07e-05	192	174	7	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RRM2B FBXL5 SLC25A40 RABGEF1 HERC3 DNA2 IQGAP3	1.07e-05	192	174	7	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 SLC4A7 MCF2L2 RNF213 ANKRD36C RSPH10B2 VPS13A	1.11e-05	193	174	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 PHYHIP IDH2 KCNJ1 PGAP1 SLC16A7 INPP5J	1.11e-05	193	174	7	fa8bcf2a5ab7b08fae98a1466a936995142b4309
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMGB1 HMGB2 HMGB3 PRIM1 RAD54B IQGAP3 AURKB	1.15e-05	194	174	7	3a49c7c86036e09a8cd0114988380d04ad1a26fb
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CASP8AP2 FBLN7 MCM8 PRIM1 RAD54B MTBP DNA2	1.19e-05	195	174	7	b65463a804fed2d9a3be9e528ca8b9c98469bc86
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 RNF213 NAA25 XRN1 MNDA MOV10 DOP1A	1.19e-05	195	174	7	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	Monocytes\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FRMD4B NRP2 S100A8 FRMD4A CCDC88A RBM47 MNDA	1.23e-05	196	174	7	ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3
ToppCell	3'-Child09-12\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SAMD9 SGK1 RNF213 APOB MEP1A SLC13A1 ABCG2	1.23e-05	196	174	7	1bcc4ffff51cdb6211824686c2422c43b09e24b2
ToppCell	Monocytes-IL1B+_Monocytes\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SGK1 FRMD4B NRP2 FRMD4A CCDC88A RBM47 MNDA	1.23e-05	196	174	7	7bc0735d324ac5a1661434cda4116ddd58296730
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 SLC4A7 MCF2L2 RNF213 ANKRD36C VPS13A XRN1	1.27e-05	197	174	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	ASK452-Immune-Macrophages\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	SGK1 S100A8 SERPINB9 CCDC88A RBM47 MNDA TOP1	1.31e-05	198	174	7	92293d389bf7d76ba057613e573c2595676ded85
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ANK2 MATN2 NEB CHRNA1 IGDCC4 GSG1L IGSF3	1.31e-05	198	174	7	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Mild-CD8+_T_activated\|Mild / Disease group and Cell class	SAMD9 RNF213 IDH2 SERPINB9 PGAP1 XRN1 DOP1A	1.31e-05	198	174	7	ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAT8L SGK1 CHRNA1 MEP1A FRMD4A CCDC88A MNDA	1.31e-05	198	174	7	0b41b3d6c2db795320e8b65d40d85fb8b618cc34
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1\|bone_marrow / Manually curated celltypes from each tissue	HMGB2 HMGB3 S100A8 CCDC88A MNDA IQGAP3 AURKB	1.31e-05	198	174	7	5c92687b853ebb00960adbef6552f9d460bc6886
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HMGB1 HMGB2 IDH2 PPP3CC SMC3 HADH AURKB	1.35e-05	199	174	7	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HMGB1 HMGB2 PRIM1 MNDA IQGAP3 IL17RB AURKB	1.35e-05	199	174	7	13ff6c26ebcc663ef8e5559ab9be99dab848abe7
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	4394dcd1809f49e9bada8f5e115d5123356eae3e
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	c0ea391bb347b99b94b5d7f02612ede938986745
ToppCell	tumor_Lung-T/NK_cells-Undetermined\|tumor_Lung / Location, Cell class and cell subclass	HMGB1 HMGB2 HMGB3 IDH2 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	2e222e2e080bc2be63d0fdf285e1790676b911ef
ToppCell	10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac\|Lung / Manually curated celltypes from each tissue	HMGB1 HMGB2 HMGB3 ABCG2 IQGAP3 IL17RB AURKB	1.35e-05	199	174	7	dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e
ToppCell	normal_Lung-T/NK_cells-Undetermined\|T/NK_cells / Location, Cell class and cell subclass	HMGB1 HMGB2 HMGB3 IDH2 PRIM1 IQGAP3 AURKB	1.35e-05	199	174	7	4142d5b1b20212508f95841fdac4efb7655616cb
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	96af1f289552f38f2dfa181192eb3276f4c7d70b
ToppCell	remission-T/NK_proliferative\|World / disease stage, cell group and cell class	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	f305f3a454b7d2170429bad087480ccccca19acd
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SEC22B FRMD4B FBXL5 S100A8 CSGALNACT2 RBM47 MNDA	1.35e-05	199	174	7	86f2857ce60fbe59375411373ff49c684fd66ad0
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBLN7 MCM8 HMGB2 NMU DNA2 IQGAP3 AURKB	1.35e-05	199	174	7	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease group, lineage and cell class	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	893b78c661c529db07a5fcc3124d9b3d0f270fa5
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	SAMD9 SLC4A7 RNF213 ANKRD36C SP140L CEBPZ XRN1	1.35e-05	199	174	7	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	5b18e18ddbf4bd53aa0d574d23092cb96da7f400
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	6df65f4c2f9a125e0c7c4f597fefc05a97fc8831
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.35e-05	199	174	7	cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08
ToppCell	Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NAT8L MATN2 MCF2L2 OGFOD1 PGBD5 IL17RB AURKB	1.35e-05	199	174	7	2b567b6fd8addf059bbf2b72c55a7647aefdc595
ToppCell	myeloid-pro-cDC\|myeloid / Lineage and Cell class	IDH2 SSRP1 YEATS4 SMC3 PRIM1 HADH AURKB	1.40e-05	200	174	7	4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf
ToppCell	mild-HLA-DR-_S100A+_Monocyte\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HTRA1 SGK1 S100A8 CCDC88A RBM47 MNDA CHP1	1.40e-05	200	174	7	6dd89835a9f7bebb4849cff8eecb82caf6e1acbf
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	MCM8 HMGB1 HMGB2 HMGB3 IDH2 SMC3 AURKB	1.40e-05	200	174	7	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SGK1 CHRNA1 MEP1A FRMD4A CCDC88A RBM47 MNDA	1.40e-05	200	174	7	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HMGB1 HMGB2 CCDC88A PRIM1 MNDA IQGAP3 AURKB	1.40e-05	200	174	7	5e1b38e2aa8901bfb2623249f7b6302e97d56ace
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	MCM8 HMGB1 HMGB2 HMGB3 IDH2 SMC3 AURKB	1.40e-05	200	174	7	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease, condition lineage and cell class	HMGB2 HMGB3 IDH2 SSRP1 YEATS4 SMC3 AURKB	1.40e-05	200	174	7	00538c4cbab5da00b3a366717d38a3ba5cfe3f65
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MCM8 HMGB1 HMGB2 SSRP1 SMC3 PRKDC AURKB	1.40e-05	200	174	7	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Stem_cells\|1m / Sample Type, Dataset, Time_group, and Cell type.	HMGB1 HMGB2 HMGB3 NMU SMC3 PRIM1 AURKB	1.40e-05	200	174	7	13636463e44a99cd886926340bfb35880f95cca6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Stem_cells-Neuroepithelial_cell\|1m / Sample Type, Dataset, Time_group, and Cell type.	HMGB1 HMGB2 HMGB3 NMU SMC3 PRIM1 AURKB	1.40e-05	200	174	7	2a3874634cc4357a64ef9fd4a6bbdfd84236ebac
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MCM8 HMGB1 HMGB2 SSRP1 SMC3 PRKDC AURKB	1.40e-05	200	174	7	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|343B / Donor, Lineage, Cell class and subclass (all cells)	MCM8 PSME4 TTC13 IL17RB AURKB GRAP	1.40e-05	133	174	6	8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae
ToppCell	COVID-19_Mild-Neu_2\|World / 5 Neutrophil clusters in COVID-19 patients	GLB1L3 TMPRSS12 RGS11 RSPH10B2 FRMD4A GABRA2	1.88e-05	140	174	6	b1429028c52f84127b894b93b55961badcd5246f
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLB1L3 TMPRSS12 RGS11 RSPH10B2 FRMD4A GABRA2	2.11e-05	143	174	6	9836a040a2ebcf6f05431e658a7b8fd566621452
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GLB1L3 TMPRSS12 RGS11 RSPH10B2 FRMD4A GABRA2	2.11e-05	143	174	6	4622c221b5d2d4cd4f37e4f81662e073924e1507
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT\|GI_small-bowel / Manually curated celltypes from each tissue	MATN2 METTL24 MTBP WDFY3 GOLGA1 GRAP	2.47e-05	147	174	6	4ba9a86ab7033688a9a2a2dc84c001a49af835b4
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L MATN2 FBXL5 S100A8 ARMH3 ABTB2	2.57e-05	148	174	6	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAT8L MATN2 FBXL5 S100A8 ARMH3 ABTB2	2.57e-05	148	174	6	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	E16.5-samps\|World / Age Group, Lineage, Cell class and subclass	HMGB1 HMGB2 HMGB3 IDH2 SSRP1 PRIM1	2.67e-05	149	174	6	e94d075f68c1c70c89fab50b1b765b5dda650d09
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN7 HMGB3 MCOLN3 RSPH10B IL17RB AURKB	3.45e-05	156	174	6	955547dfeb1b1ad4957b4338701055726b22619f
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAT8L HMGB2 S100A8 MNDA IQGAP3 AURKB	3.58e-05	157	174	6	904cd98ae85ed6459e0663f077ac462842bf12df
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMGB2 NEB KCNJ1 PRIM1 RAD54B HERC3	3.98e-05	160	174	6	5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEB NAP1L6P NMU RAD54B IQGAP3 AURKB	4.12e-05	161	174	6	2165897924c790fec43502283f1df221c56c1e9f
ToppCell	Influenza_Severe-Neutrophil\|Influenza_Severe / Disease group and Cell class	IL18R1 MYO5C S100A8 WDFY3 MNDA RSPH9	4.12e-05	161	174	6	98c95b1b85d5427415af2ca8fb14849e97f6e8b5
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 CFAP100 HOXB1 GSG1L INPP5J TMEM117	4.26e-05	162	174	6	b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCell	facs-SCAT-Fat-18m-Epithelial\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIDEB GPT DNAJC22 MEP1A INPP5J TMEM117	4.26e-05	162	174	6	341fa357ad7bdbef30864e8062f161e60185ffc9
ToppCell	facs-SCAT-Fat-18m-Epithelial-epithelial_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIDEB GPT DNAJC22 MEP1A INPP5J TMEM117	4.26e-05	162	174	6	7215f6eb2b65dea455e2eec722a9c38e6958b120
ToppCell	facs-SCAT-Fat-18m-Epithelial-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIDEB GPT DNAJC22 MEP1A INPP5J TMEM117	4.26e-05	162	174	6	7fa93efa2039d68a4e8214fa143bcd3368349a2d
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTRA1 SGK1 MCF2L2 FRMD4A SERPINB9 ABCG2	4.41e-05	163	174	6	a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPT LONRF2 DNAH5 RSPH9 IQGAP3 AURKB	4.56e-05	164	174	6	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPT LONRF2 DNAH5 RSPH9 IQGAP3 AURKB	4.56e-05	164	174	6	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIDEB GPT APOB MEP1A ABCG2 CHP1	4.72e-05	165	174	6	ce79d217df88035457cd58f679e72dd98722ae22
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CIDEB GPT MEP1A ABCG2 INPP5J CHP1	4.88e-05	166	174	6	22b31acbbef1936ce19b393cf880c63ea2fa0f1b
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	S100A8 FBXO38 CXorf58 MNDA ABTB2 MOV10	5.05e-05	167	174	6	820472887f43b42ae7e44513ca3d5465fb4f71a7
Drug	Stallimycin	HMGB1 HMGB2 HMGB3 SSRP1 SMC3 PRIM1 TOP1MT TOP3B TOP1	1.05e-08	80	174	9	CID000003115
Drug	AC1L36FJ	HMGB1 HMGB2 HMGB3 SSRP1 PRKDC	4.54e-07	21	174	5	CID000083911
Drug	Edotecarinum	ABCG2 TOP1MT TOP3B TOP1	6.68e-07	10	174	4	CID000151078
Drug	BNP1350	ABCG2 TOP1MT TOP3B TOP1	1.56e-06	12	174	4	CID000148202
Drug	C20H16N2O5	HMGB1 HMGB2 TOP1MT TOP3B TOP1	1.73e-06	27	174	5	CID000119122
Drug	Vincristine	CUL4A CYP2C9 SLC4A7 VPS72 SGK1 MATN2 HECTD4 HMGB1 RNF213 CREBBP MRPL39 S100A8 NAA25 PSME4 SP140L CD80 PRIM1 VPS13A ABCG2 PRKDC DNA2 ABTB2 IL17RB SYNCRIP AURKB	3.81e-06	1182	174	25	ctd:D014750
Drug	NSC 314622	TOP1MT TOP3B TOP1	4.34e-06	5	174	3	CID000329826
Drug	4-demethoxy-11-deoxy-4'-epi-daunorubicin	TOP1MT TOP3B TOP1	4.34e-06	5	174	3	CID000158476
Drug	4-demethyl-6-O-methyldoxorubicin	TOP1MT TOP3B TOP1	4.34e-06	5	174	3	CID000126902
Drug	2-bromo-dATP	TOP1MT TOP3B TOP1	4.34e-06	5	174	3	CID000129443
Drug	NSC622082	TOP1MT TOP3B TOP1	4.34e-06	5	174	3	CID000494392
Drug	eupolauridine	TOP1MT TOP3B TOP1	4.34e-06	5	174	3	CID000072486
Drug	d(GpG	HMGB1 HMGB2 HMGB3 SSRP1 PRKDC	6.63e-06	35	174	5	CID000161113
Drug	intoplicine	TOP1MT TOP3B TOP1	8.63e-06	6	174	3	CID000065954
Drug	galbacin	GPT TOP1MT TOP1	8.63e-06	6	174	3	CID000234441
Drug	UCE6	TOP1MT TOP3B TOP1	8.63e-06	6	174	3	CID000127735
Drug	ethoxidine	TOP1MT TOP3B TOP1	8.63e-06	6	174	3	CID000476777
Drug	BE-10988	TOP1MT TOP3B TOP1	8.63e-06	6	174	3	CID000126200
Drug	saintopin	TOP1MT TOP3B TOP1	8.63e-06	6	174	3	CID000131350
Drug	azalanstat	CYP2C9 CYP51A1 APOB CRAMP1	9.27e-06	18	174	4	CID000060876
Drug	10-hydroxycamptothecin	PDE6A ABCG2 TOP1MT TOP3B TOP1	1.30e-05	40	174	5	CID000097226
Drug	Demecolcine	CUL4A SLC4A7 VPS72 SGK1 RRM2B HECTD4 PSME4 SP140L SMC3 CD80 MACO1 PRIM1 PGAP1 VPS13A PRKDC DNA2 ABTB2 IL17RB SYNCRIP AURKB	1.35e-05	878	174	20	ctd:D003703
Drug	nitidine	TOP1MT TOP3B TOP1	1.50e-05	7	174	3	CID000004501
Drug	D01432	ABCG2 TOP1MT TOP1	1.50e-05	7	174	3	CID011954228
Drug	AC1L4GCF	TOP1MT TOP3B TOP1	1.50e-05	7	174	3	CID000156514
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A	CUL4A FBXO38 RINT1 CCDC88A SMC3 MCM3AP PRKDC HADH DOP1A	2.16e-05	197	174	9	1386_DN
Drug	ZINC03993519	ABCG2 TOP1MT TOP3B TOP1	2.16e-05	22	174	4	CID006440178
Drug	9-HME	TOP1MT TOP3B TOP1	2.39e-05	8	174	3	CID003034753
Drug	NSC-294410	TOP1MT TOP3B TOP1	2.39e-05	8	174	3	CID000457914
Drug	dPMC	APOB RNPEP SMC3	3.56e-05	9	174	3	CID000125296
Drug	ardisin	TOP1MT TOP3B TOP1	3.56e-05	9	174	3	CID000417291
Drug	IST-622	TOP1MT TOP3B TOP1	3.56e-05	9	174	3	CID003081749
Drug	o-AMSA	TOP1MT TOP3B TOP1	3.56e-05	9	174	3	CID000107747
Drug	ethidium bromide	CHRNA1 SLC13A1 SMC3 TOP1MT TOP3B TOP1	4.85e-05	85	174	6	CID000003624
Drug	dFdCTP	RRM2B PRIM1 ABCG2 TOP1	5.04e-05	27	174	4	CID000130659
Drug	AC1MZ4R5	TOP1MT TOP3B TOP1	5.06e-05	10	174	3	CID003842392
Drug	diospyrin	TOP1MT TOP3B TOP1	5.06e-05	10	174	3	CID000308140
Drug	Irinotecan	TOP1MT TOP1	5.81e-05	2	174	2	DB00762
Drug	Topotecan	TOP1MT TOP1	5.81e-05	2	174	2	DB01030
Drug	AC-759	CYP2C9 SLC4A7 PRIM1 TOP1MT TOP3B TOP1	5.90e-05	88	174	6	CID000005396
Drug	Magnetite Nanoparticles	SMG1 CASP8AP2 SLC4A7 RRM2B CYP51A1 RNF213 HMGB2 CREBBP MECP2 FRMD4B NRP2 NEDD9 S100A8 IGF2BP1 SERPINB9 CCDC88A CSGALNACT2 CD80 MNDA ABTB2 MOV10 IGSF3 SYNCRIP GRAP	6.24e-05	1310	174	24	ctd:D058185
Drug	AC1L1COZ	NAA15 IDH2 CREBBP MCM3AP VPS13A EP300	6.69e-05	90	174	6	CID000001996
Drug	9-aminocamptothecin	ABCG2 TOP1MT TOP3B TOP1	6.74e-05	29	174	4	CID000072402
Drug	merbarone	PRIM1 TOP1MT TOP1	6.92e-05	11	174	3	CID004990817
Drug	MDO-CPT	TOP1MT TOP3B TOP1	6.92e-05	11	174	3	CID000072403
Drug	p-acetaminobenzaldehyde thiosemicarbazone	RRM2B TOP1MT DNAH5 TOP3B TOP1	8.82e-05	59	174	5	CID002733749
Drug	SN-38G	ABO ABCG2 TOP1MT TOP3B TOP1	8.82e-05	59	174	5	CID000443154
Drug	AC1L6D6Y	TOP1MT TOP3B TOP1	9.17e-05	12	174	3	CID000265082
Drug	BD-40	TOP1MT TOP3B TOP1	9.17e-05	12	174	3	CID000068853
Drug	AC1L9QTR	TOP1MT TOP3B TOP1	9.17e-05	12	174	3	CID000453215
Drug	ellipticine derivative	TOP1MT TOP3B TOP1	9.17e-05	12	174	3	CID000434612
Drug	NC-190	TOP1MT TOP3B TOP1	9.17e-05	12	174	3	CID000129234
Drug	Succimer	SMG1 CASP8AP2 SLC4A7 RRM2B CYP51A1 RNF213 HMGB2 CREBBP MECP2 FRMD4B NRP2 S100A8 IGF2BP1 SERPINB9 CCDC88A CSGALNACT2 CD80 MNDA ABTB2 MOV10 IGSF3 SYNCRIP GRAP	9.96e-05	1264	174	23	ctd:D004113
Drug	vinblastine	IFNK SLC4A7 SPAST CHRNA1 ABCG2 TOP1MT TOP3B TOP1	1.06e-04	189	174	8	CID000013342
Drug	9-NC	ABCG2 TOP1MT TOP3B TOP1	1.13e-04	33	174	4	CID000123613
Drug	diflomotecan	ABCG2 TOP1MT TOP3B TOP1	1.13e-04	33	174	4	CID000219023
Drug	4 pN	TOP1MT TOP3B TOP1	1.19e-04	13	174	3	CID000078607
Drug	AC1L8YYB	ABCG2 TOP1MT TOP3B TOP1	1.28e-04	34	174	4	CID000435167
Drug	Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A	SAMD9 JMJD4 NEB MECP2 NEDD9 PGAP1 HERC3 INPP5J	1.32e-04	195	174	8	6259_UP
Drug	AC1L1FWE	PPP3CC PRKDC TOP1MT TOP3B TOP1 AURKB	1.34e-04	102	174	6	CID000003422
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; HL60; HG-U133A	FBXL5 CCDC88A SLC25A40 SP140L SNX6 MCM3AP PDCD11 ARMH3	1.37e-04	196	174	8	1770_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	FBXL5 PGAP1 MCM3AP VPS13A DNA2 SLC16A7 IL17RB CHP1	1.37e-04	196	174	8	6058_DN
Drug	Dicloxacillin	GPT HMGB1 S100A8	1.50e-04	14	174	3	ctd:D004009
Drug	9-hydroxyellipticine	TOP1MT TOP3B TOP1	1.50e-04	14	174	3	CID000091643
Drug	DX-8951f	ABCG2 TOP1MT TOP1	1.50e-04	14	174	3	CID000151114
Drug	AC1L7AJI	CYP2C9 CD80 ABCG2 PRKDC TOP1MT TOP3B TOP1 EP300 AURKB	1.63e-04	256	174	9	CID000003750
Drug	perylenediimide	TOP1MT TOP1	1.73e-04	3	174	2	CID000066475
Drug	chavibetol	TOP1MT TOP1	1.73e-04	3	174	2	CID000596375
Drug	2,2,5,5-tetramethylimidazolidin-4-one	TOP1MT TOP1	1.73e-04	3	174	2	CID009812798
Drug	v 2182	TOP1MT TOP1	1.73e-04	3	174	2	CID000078632
Drug	plakinidine A	TOP1MT TOP1	1.73e-04	3	174	2	CID005468016
Drug	N-ethylethylenediamine	TOP1MT TOP1	1.73e-04	3	174	2	CID000066071
Drug	potassium hydroxide	PHYHIP APOB NRP2 PRIM1 PLOD2 CRAMP1	1.84e-04	108	174	6	CID000014797
Drug	tanshinone	CYP2C9 HMGB1 ABCG2	1.87e-04	15	174	3	CID000114917
Drug	protoberberine	TOP1MT TOP3B TOP1	1.87e-04	15	174	3	CID000114943
Drug	lurtotecan	ABCG2 TOP1MT TOP1	1.87e-04	15	174	3	CID000060955
Drug	mitoxantrone	IFNK GPT IGDCC4 ABCG2 TOP1MT TOP3B TOP1	1.87e-04	154	174	7	CID000004212
Disease	myocardial infarction	HTRA1 ABO VPS72 DOCK9 HECTD4 APOB IGF2BP1 NAA25 ABCG2 CCDC63	3.14e-05	350	166	10	EFO_0000612
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	3.15e-05	2	166	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	3.15e-05	2	166	2	cv:C4551859
Disease	Menke-Hennekam syndrome	CREBBP EP300	3.15e-05	2	166	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	3.15e-05	2	166	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	3.15e-05	2	166	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	3.15e-05	2	166	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	3.15e-05	2	166	2	DOID:1933 (is_implicated_in)
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	3.15e-05	2	166	2	C0035934
Disease	drinking behavior	HECTD4 CCDC63	9.40e-05	3	166	2	EFO_0004315
Disease	alcohol drinking	HECTD4 HEATR1 HMGB1P1 LONRF2 CCDC63	9.63e-05	81	166	5	EFO_0004329
Disease	Neurodevelopmental Disorders	SPAST ANK2 MECP2 SMC3 WDFY3	1.85e-04	93	166	5	C1535926
Disease	Diffuse Large B-Cell Lymphoma	SGK1 CREBBP ABCG2 EP300	2.63e-04	55	166	4	C0079744
Disease	Leukemia, Myelocytic, Acute	SGK1 ANXA4 IDH2 CREBBP S100A8 EP300	4.56e-04	173	166	6	C0023467
Disease	Flaccid Muscle Tone	RRM2B MECP2	4.65e-04	6	166	2	C0026825
Disease	Neonatal Hypotonia	RRM2B MECP2	4.65e-04	6	166	2	C2267233
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	NEB CHRNA1	4.65e-04	6	166	2	C1854678
Disease	intercellular adhesion molecule 2 measurement	ABO NAA25	4.65e-04	6	166	2	EFO_0008163
Disease	Muscle Tone Atonic	RRM2B MECP2	4.65e-04	6	166	2	C0427202
Disease	Floppy Muscles	RRM2B MECP2	4.65e-04	6	166	2	C0427201
Disease	interleukin-1 receptor-like 1 measurement	ABO IL18R1	4.65e-04	6	166	2	EFO_0801713
Disease	Unilateral Hypotonia	RRM2B MECP2	4.65e-04	6	166	2	C0751330
Disease	hypertension (is_implicated_in)	HTRA1 CYP2C9 ABO SGK1 MOV10	6.24e-04	121	166	5	DOID:10763 (is_implicated_in)
Disease	lithostathine-1-alpha measurement	HTRA1 ABO	6.49e-04	7	166	2	EFO_0801083
Disease	glypican-1 measurement	NRAP HABP2	6.49e-04	7	166	2	EFO_0801649
Disease	coffee consumption	LAMB4 HECTD4 NAA25	7.69e-04	32	166	3	EFO_0004330
Disease	tea consumption measurement	HECTD4 PHYHIP FRMD4B NAA25 ABCG2	8.33e-04	129	166	5	EFO_0010091
Disease	Primary ciliary dyskinesia	ODAD2 DNAH5 RSPH9	1.09e-03	36	166	3	cv:C0008780
Disease	visceral heterotaxy (implicated_via_orthology)	ODAD2 PSME4 DNAH5	1.18e-03	37	166	3	DOID:0050545 (implicated_via_orthology)
Disease	Drug toxicity	CYP2C9 HMGB1 ABCG2 TOP1	1.31e-03	84	166	4	C0013221
Disease	Adverse reaction to drug	CYP2C9 HMGB1 ABCG2 TOP1	1.31e-03	84	166	4	C0041755
Disease	obstructive jaundice (biomarker_via_orthology)	GPT HMGB1	1.37e-03	10	166	2	DOID:13603 (biomarker_via_orthology)
Disease	lipoprotein-associated phospholipase A(2) measurement	RNF213 APOB ABCG2	1.48e-03	40	166	3	EFO_0004746
Disease	high grade glioma (implicated_via_orthology)	HMGB1 IDH2 CD80	1.96e-03	44	166	3	DOID:3070 (implicated_via_orthology)
Disease	alcohol consumption measurement, alcohol drinking	HECTD4 CCDC63	2.00e-03	12	166	2	EFO_0004329, EFO_0007878
Disease	Primary Ciliary Dyskinesia	ODAD2 DNAH5 RSPH9	2.36e-03	47	166	3	C4551720
Disease	Kartagener syndrome (implicated_via_orthology)	ODAD2 DNAH5	2.74e-03	14	166	2	DOID:0050144 (implicated_via_orthology)
Disease	lipoprotein measurement	ABO APOB NAA25 TASOR	2.97e-03	105	166	4	EFO_0004732
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	ABO APOB	3.15e-03	15	166	2	EFO_0022328
Disease	response to statin, LDL cholesterol change measurement	APOB ABCG2	3.15e-03	15	166	2	EFO_0007804, GO_0036273
Disease	Muscle hypotonia	RRM2B MECP2	4.05e-03	17	166	2	C0026827
Disease	Moyamoya Disease	HTRA1 RNF213	4.05e-03	17	166	2	C0026654
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	ABO APOB	4.05e-03	17	166	2	EFO_0022232
Disease	X-12063 measurement	DNAH14 HMGB1P1 MACO1 DNAH5 PGBD5	4.12e-03	186	166	5	EFO_0021283
Disease	creatine kinase measurement	ABO NEB IQGAP3	4.51e-03	59	166	3	EFO_0004534
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	ABO APOB MACO1 TOP1	4.79e-03	120	166	4	EFO_0004611, EFO_0004639
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ABO SPG11 APOB	4.96e-03	61	166	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	diabetes mellitus (biomarker_via_orthology)	CYP51A1 ABCG2	5.05e-03	19	166	2	DOID:9351 (biomarker_via_orthology)
Disease	cerebral infarction (is_marker_for)	HMGB1 APOB	5.05e-03	19	166	2	DOID:3526 (is_marker_for)
Disease	factor VIII measurement, Ischemic stroke	ABO HECTD4	5.05e-03	19	166	2	EFO_0004630, HP_0002140
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	ABO APOB NAA25	5.42e-03	63	166	3	EFO_0001645, EFO_0004792
Disease	Acute Myeloid Leukemia, M1	SGK1 ANXA4 IDH2 S100A8	5.52e-03	125	166	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	SGK1 ANXA4 IDH2 S100A8	5.52e-03	125	166	4	C1879321

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEKLSRFHAKFTLEY	GPT	481	P24298
DFLEKIAKLYELHVF	CTDP1	231	Q9Y5B0
SERIVHDYKDIFKQA	EP300	1476	Q09472
SFLKAYVHEFKFRSI	RNPEP	436	Q9H4A4
YVAFLKLFLETAEKH	ABO	126	P16442
AAEFYVTHEILKKVA	CXorf58	71	Q96LI9
AVDKVELFLKEYLHF	NEDD9	451	Q14511
ELFLKEYLHFVKGAV	NEDD9	456	Q14511
AVVTYIAFHKLRKDY	ADGRG4	2761	Q8IZF6
YTKTVIEFRHKRKVF	GSG1L	241	Q6UXU4
QHFKVLREASGKYFL	GRAP	106	Q13588
ELFVVEKKLFIHEYI	ABCG2	446	Q9UNQ0
FAERIIHDYKDIFKQ	CREBBP	1511	Q92793
YSEQHKEAAFFKELV	ARMH3	646	Q5T2E6
LRYIAEKTEFFKHVA	DOP1A	861	Q5JWR5
LHVFDEYKRISQKDI	ANXA4	206	P09525
YEKDAFKREHLAEVT	CD80	121	P33681
FKAKFSLIQFHRIIE	CASP8AP2	1056	Q9UKL3
RLYEVKLVAFNKHED	IGDCC4	711	Q8TDY8
DHKVEEFIKSIFYSV	RAD54B	391	Q9Y620
RVKKIRDYAFVHFTS	RBM47	276	A0AV96
FKKHRAARIDHYVVE	RBSN	106	Q9H1K0
DRVSKEFIEFLKTFH	RABGEF1	136	Q9UJ41
KSADFHKREIEYFRK	RGS11	221	O94810
DHEVLTFIKYKVFDA	HNRNPLL	476	Q8WVV9
DAIRAIYAEDHKLVF	MON1B	151	Q7L1V2
SEHETRLVAKLFKDY	CHRNA1	21	P02708
KESKEHFFDLYRNSI	ANK2	3461	Q01484
IHRAVFYRDLEELKF	ANKRD36C	36	Q5JPF3
NTLFHAYKREEAIKE	RSPH10B	771	P0C881
NTLFHAYKREEAIKE	RSPH10B2	771	B2RC85
RKFGSKYLVDHEVHF	FBLN7	91	Q53RD9
ALVYRDRETLKFVKH	OGFOD1	501	Q8N543
KHFGYKLCIFERDVV	IL18R1	406	Q13478
RSVNTHDYAKVKEFI	MATN2	66	O00339
REINFEYLKHVVLKF	GOLGA1	691	Q92805
YAFFVQTCREEHKKK	HMGB1	16	P09429
DEKDNTKRFLFHYSK	NMU	96	P48645
KFFTRHIDLYDKDEI	MCM8	101	Q9UJA3
EFVNFFLLHYKKEVS	MCOLN3	316	Q8TDD5
FLYRHDFVKERGKLI	NRAP	1306	Q86VF7
YAFFVQTCREEHKKK	HMGB2	16	P26583
SFLVHESFLYKREKA	FLYWCH1	281	Q4VC44
KSFIEAVEKYFDHLI	GLB1L3	191	Q8NCI6
FKRLDKFAAEHTIFA	HADH	131	Q16836
ADRFKYHIVKQIFSG	HERC3	356	Q15034
ADLEKVFAEHKISYS	IGF2BP1	16	Q9NZI8
FTRRSKKLAVVHFFD	MCM3AP	466	O60318
HKYVVVYFREIDTKD	IL17RB	441	Q9NRM6
TAHFHLKRKIGYFVI	GABRA2	241	P47869
LVEFSHKELFDFYNK	COMMD10	176	Q9Y6G5
LHDIEFYKARVEELK	CCDC88A	336	Q3V6T2
RVKKLKDYAFIHFDE	SYNCRIP	366	O60506
FVYIEAAIRFKDLKN	MACO1	131	Q8N5G2
LYEFHNRTFLKELEK	MCF2L2	676	Q86YR7
SHFTKRDEEILLKYL	PDE6A	201	P16499
DLLYIRDHFDKKQVF	FAM151B	241	Q6UXP7
RDHFDKKQVFYDILE	FAM151B	246	Q6UXP7
EARAFVRKFKVSYSL	NRP2	516	O60462
EKVNKYLDFSLFKHR	SLC16A7	231	O60669
KEFAEKLESLLHRAY	MIGA2	231	Q7L4E1
VLYFILGLHFEEDKK	LONRF2	371	Q1L5Z9
KYLTLEGFHKFVIDR	HECTD4	3406	Q9Y4D8
NDYLEETHLKFRKFI	IQGAP3	1236	Q86VI3
KIETHLFAFEIYFRK	NAA15	671	Q9BXJ9
EVYHEKDIKVFFDKA	PLOD2	336	O00469
YVKVFEHFLENLDKS	PRIM1	391	P49642
ARFEKILKYFHVVAF	PGBD5	206	Q8N414
KKGVFQRVVAIFIHY	FBXO38	1161	Q6PIJ6
FHYIREALKSDKLAQ	QTRT2	391	Q9H974
ENLYFREKKFSVEVH	FRMD4A	261	Q9P2Q2
DLVASHFNLKEKEYF	FRMD4B	86	Q9Y2L6
HFNLKEKEYFGITFI	FRMD4B	91	Q9Y2L6
NLYFREKKFAVEVHD	FRMD4B	301	Q9Y2L6
HEQSFRVEKIFKYSH	HABP2	386	Q14520
VIRKGSKNDFFLHYI	APOB	816	P04114
FFKKADLTEYRHVTL	CSGALNACT2	236	Q8N6G5
TELEKEFHFNKYLSR	HOXB1	216	P14653
RFKDIFQEIFDKHYK	IDH2	261	P48735
VAKESDSVFVLKIYH	IGSF3	351	O75054
RHKYNFIADVVEKIA	HTRA1	166	Q92743
ELERLYAHESKLKSF	CCDC63	251	Q8NA47
IKYNRKISADFHVDL	DOCK9	406	Q9BZ29
YISALRKLFDQHKVE	DGAT2L6	311	Q6ZPD8
RFIHGKDVFEAFYKK	CUL4A	441	Q13619
EEFYHFLKVIAEKRL	JMJD4	381	Q9H9V9
RAHREIKDIFYKAIQ	CYP51A1	261	Q16850
HKITKYIDFDHVFSR	CRAMP1	221	Q96RY5
FHRIDNFLKEKKYSD	IFNK	166	Q9P0W0
ISRFEDTLKHYKVYK	CFAP100	246	Q494V2
ELELKARVFHFGEYK	CFAP100	456	Q494V2
FLVKVGFLKILHRYE	C20orf27	51	Q9GZN8
LAKVTYDFDKLVHEL	DNAH14	1801	Q0VDD8
QKFDTLLAAFRHYDK	EFHB	561	Q8N7U6
YAFFVQTCREEHKKK	HMGB3	16	O15347
FLKVKDYHDSVRRQI	LAMB4	1241	A4D0S4
KIFLFDTQHFISKER	HEATR1	2001	Q9H583
HAEERQKFFKYSVDE	FBXL5	176	Q9UKA1
NVICSIIFHKRFDYK	CYP2C9	176	P11712
SDRDKFVIFLDVKHF	CRYAA	66	P02489
AKLYEFVHSFQDEKR	DNAJC22	261	Q8N4W6
RHFKDVKLELEFYAD	DNA2	861	P51530
KKLAFAYLEDLHSEF	SEC22B	81	O75396
KVASAYFKDFHLLLI	SLC13A1	76	Q9BZW2
EVFFHRYYKKVAVKE	CEBPZ	811	Q03701
SVKFHEKIYDRILSI	DNAH5	1751	Q8TE73
KFIYGEKHVEVRTLA	DNAH5	3186	Q8TE73
FLGLKRVVTDKHFYF	HS3ST6	266	Q96QI5
TRKHFLDYFDAVIPK	MTBP	506	Q96DY7
AKYLREFHSVERKFA	NAP1L6P	66	A6NFF2
RYAREHLAKSKLEVF	PLA2G4D	386	Q86XP0
AFRSKVELIAYFEKV	MECP2	131	P51608
YFHVKVFDINLKEKF	MNDA	246	P41218
LKELEQKDFRLFHSY	METTL24	321	Q5JXM2
ALEIFQHSKYKVDFI	MRPL39	226	Q9NYK5
AKKLSSYFHFREPVE	RSPH9	181	Q9H1X1
FHAVYRDDLKKLLET	S100A8	26	P05109
KFEKEELESHRAVYI	SLC4A7	31	Q9Y6M7
FYGVKFRNKVSHIDV	SMC3	1186	Q9UQE7
YVELHRFVSKKVSED	SLC25A40	176	Q8TBP6
ITYKGFVHKVELDRV	MOV10	411	Q9HCE1
AKFKELIFQVRHTYE	RIT2	111	Q99578
VVKAYKESRVANLHF	SAMD9	451	Q5K651
LKEIIVFVESFIYKH	ODAD2	31	Q5T2S8
HIIKLTFEDFAVKFS	OVCH1	456	Q7RTY7
KVLLARHKAEEVFYA	SGK1	111	O00141
RHKAEEVFYAVKVLQ	SGK1	116	O00141
LFLRYHKEKEVVAVA	SMG1	531	Q96Q15
YAFFVQTCREEHKKK	HMGB1P1	16	B2RPK0
AHVVLKEEQKFRYLF	MEP1A	391	Q16819
TQFLQYFLEKREKHV	THNSL2	121	Q86YJ6
SIALRKAEDIDFKYH	PGAP1	106	Q75T13
LERVTHYFIDLNKKE	PHYHIP	31	Q92561
RTYHLCEVLFKVHKF	SNTG2	346	Q9NY99
VRVFHKQAFEYISIA	SPAST	116	Q9UBP0
EGLVYDTVFKHFKRH	SP140L	46	Q9H930
EFEKLSDFFKTHYRL	SSRP1	81	Q08945
HSVVEKYVSEFFKRG	TASOR	551	Q9UK61
DVTFLVEGKLFYAHK	ABTB2	846	Q8N961
KHSKDIARFTFDVYK	CIDEB	126	Q9UHD4
HFAFRLYDLDKDEKI	CHP1	116	Q99653
TRAEFQAKIDAVKHY	CNGA2	381	Q16280
VYLAREKKSHFIVAL	AURKB	91	Q96GD4
VRDFFPTVFVKEKHY	PROKR1	306	Q8TCW9
LKADEKYFISHILAF	RRM2B	81	Q7LG56
FRIESYDLHFVKFAI	INPP5J	606	Q15735
YFSEKEKRTIDFVHQ	SPG11	781	Q96JI7
HLTDYFTFKQECRIK	PPP3CC	151	P48454
FRLIVIEEKDVVYKH	RNF213	3146	Q63HN8
VLGHTLDVFKRKFHY	TOP3B	581	O95985
LDVFKRKFHYFVDSI	TOP3B	586	O95985
LKVFLHLADIYAKSE	PDCD11	1691	Q14690
TEHKRFLAFEVKEYS	RWDD3	226	Q9Y3V2
FKDDLFRKYVQFHES	SPATA2	11	Q9UM82
YFEKILHFIKDRILV	TTC13	616	Q8NBP0
KVFQLIFYFKEHERI	ZNF540	306	Q8NDQ6
ELHRFVSVSKLKYFF	YIF1A	81	O95070
KFFLDSYKLVIHQRI	ZNF749	591	O43361
FHKDIEAFKEEYKTA	VPS13A	2741	Q96RL7
IKLSFKEHGQIEFYR	VPS36	106	Q86VN1
LLKFTRHDYIFKDVF	WDFY3	486	Q8IZQ1
FYHAELKELSFIRAA	SERPINB9	111	P50453
VDHVFREVKDAAKLY	RINT1	611	Q6NUQ1
SAVYDVFVFHRLKIK	TMTC2	196	Q8N394
FEKYLVKLSDFDREH	XRN1	336	Q8IZH2
DHEYTTKEVFRKNFF	TOP1MT	101	Q969P6
DIALFHLKKAVRYND	TMPRSS12	171	Q86WS5
DKRVKDFLHAVYATL	SERPINE3	86	A8MV23
VFEKKYHQVDVRFPA	PPP1R36	331	Q96LQ0
RIIFVFDFKKVSLLH	nan	206	Q6ZUG5
YGRKFSKEDHVLFIK	PSME4	86	Q14997
FLLEYHNRVKDASAK	SNX6	216	Q9UNH7
TECRHKSIELFYKFV	PRKDC	1181	P78527
IEALKNRFKYFESDH	UACA	366	Q9BZF9
HLFLKYSFRKDIFGD	PRSS21	206	Q9Y6M0
FQKIFKEEYRIHITG	TMEM117	286	Q9H0C3
FKIIREAYKKYITAH	VPS72	316	Q15906
YKHETEFAELEVKTR	YEATS4	166	O95619
HEYTTKEIFRKNFFK	TOP1	266	P11387
FRHDKVYVIGSFVDK	TRMT10C	301	Q7L0Y3
KYRVDFHNFSKTVEV	KCNJ1	336	P48048
LAKKIYAHLFDFIVE	MYO5C	401	Q9NQX4
HYSAEKAVKFIEDRI	NAA25	296	Q14CX7
VKVAAHKLYESLGFR	NAT8L	251	Q8N9F0
SHIKYREEYEKFKAL	NEB	4736	P20929
KYHTVKDALDIVYHR	NEB	5276	P20929